ASPG and acute lymphoblastic leukemia: (20) reviewed 10 studies, that met statistical criteria, from a pool of 1,842 screened articles and identified older age, asparaginase formulation, higher ALL risk stratification, and higher asparaginase dosing regimen as the most potential risk factors for the occurrence of AAP.